New test could help IVF patients pick the best embryo without invasive biopsy

NCT ID NCT07359703

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new test called the Aurora test, which uses cells that normally surround the egg (cumulus cells) to help select the best embryo for transfer in IVF. The test is non-invasive and aims to improve pregnancy and live birth rates compared to the standard method of judging embryos by appearance alone. About 1,028 women undergoing ICSI will participate, and the study will compare embryo selection based on morphology versus morphology plus the Aurora test.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Aurora test (non-invasive genetic analysis of cumulus cells)

What this could lead to

If successful, this test could provide a more objective way to choose the embryo with the highest chance of pregnancy, potentially improving IVF success rates without invasive procedures.

What could go wrong

This is an early-stage study comparing the test to standard methods, and it may not show a significant improvement. The test is also specific to certain stimulation protocols, so results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY ASSISTED REPRODUCTIVE TECHNOLOGY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ghent University Hospital

    RECRUITING

    Ghent, Belgium

    Contact Phone: •••-•••-•••• Email: •••••@•••••